MRNA Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

52.780

Open

51.640

VWAP

50.80

Vol

7.55M

Mkt Cap

19.84B

Low

49.580

Amount

383.46M

EV/EBITDA(TTM)

Total Shares

396.59M

14.98B

EV/OCF(TTM)

P/S(TTM)

10.17

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).

Events Timeline

(ET)

2026-03-16

18:50:00

Boston Judge Backs Medical Groups Against HHS Policy Changes

2026-03-09 (ET)

2026-03-09

16:30:00

Moderna Shares Rise 5.85% to $55.59

2026-03-09

10:00:00

Live Nation and Other Liquid Option Stocks Gain

2026-03-08 (ET)

2026-03-08

22:30:00

KKR Plans to Sell CoolIT Systems for Over $3B

2026-03-08

17:00:00

Dr. Vinay Prasad to Leave Agency at End of April

News

4.5

04-01seekingalpha

Healthcare Sector Faces Significant Decline Amid Market Challenges

9.5

03-27NASDAQ.COM

Moderna Stock Drops 7.49% Amid Earnings Anticipation

8.0

03-27NASDAQ.COM

Moderna and Kodak Options Show High Trading Volume

5.0

03-26Fool

Investment Outlook for Healthcare Stocks

5.0

03-26NASDAQ.COM

Biotech Companies Show Promising Clinical Progress

5.0

03-25seekingalpha

Trump Administration Delays Nomination for CDC Director

20 Analyst Rating

Wall Street analysts forecast MRNA stock price to rise

1 Buy

16 Hold

3 Sell

Hold

Current: 0.000

Low

17.00

Averages

32.47

High

63.00

Current: 0.000

Low

17.00

Averages

32.47

High

63.00

Barclays

Equal Weight

maintain

$25 -> $48

AI Analysis

2026-04-01

New

Reason

Barclays

Price Target

$25 -> $48

AI Analysis

2026-04-01

New

maintain

Equal Weight

Reason

Barclays raised the firm's price target on Moderna to $48 from $25 and keeps an Equal Weight rating on the shares.

BofA

Underperform

maintain

$31

2026-03-04

Reason

BofA

Price Target

$31

2026-03-04

maintain

Underperform

Reason

BofA contends that Moderna's (MRNA) settlement with Arbutus (ABUS) and Genevant (ROIV) takes "a meaningful chunk of the litigation overhang off the table," but adds that the agreement is "also not the walk-away outcome we expect some bulls were hoping for." The structure leaves "a contingent tail" as Moderna could owe an additional payment of up to $1.3B if the Federal Circuit ultimately affirms liability, notes the analyst, who reiterates an Underperform rating and $31 price target on Moderna shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MRNA

Unlock Now

Valuation Metrics

The current forward P/E ratio for Moderna Inc (MRNA.O) is 23.04, compared to its 5-year average forward P/E of -1.05. For a more detailed relative valuation and DCF analysis to assess Moderna Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-1.05

Current PE

23.04

Overvalued PE

13.10

Undervalued PE

-15.20

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-2.48

Current EV/EBITDA

-6.42

Overvalued EV/EBITDA

7.14

Undervalued EV/EBITDA

-12.10

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

6.42

Current PS

7.83

Overvalued PS

9.09

Undervalued PS

3.76

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

us stocks and ETFs

Intellectia · 56 candidates

Region: USPrice: $10.00 - $150.00Beta: HighRiskList Exchange: XNYS, XNAS, XASEMin5 Price Change Pct: $0.40 - $2.50Monthly Average Dollar Volume: >= 5,000,000

Ticker

Name

Market Cap$

MRVL

Marvell Technology Inc

79.99B

SHOP

Shopify Inc

165.07B

ONDS

Ondas Inc

4.73B

Barrick Mining Corp

72.21B

RBLX

Roblox Corp

41.93B

MRNA

Moderna Inc

21.05B

momentum stocks

Intellectia · 54 candidates

Market Cap: >= 5.00BRsi Category: moderate, overboughtList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Month Price Change Pct: >= $15.00

Ticker

Name

Market Cap$

IBRX

Immunitybio Inc

8.63B

AAOI

Applied Optoelectronics Inc

7.28B

TPL

Texas Pacific Land Corp

36.62B

SSL

Sasol Ltd

7.21B

MRNA

Moderna Inc

20.76B

ACLX

Arcellx Inc

6.69B

what stock should I buy rn

Intellectia · 7 candidates

Price: $10.00 - $80.00List Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20Month Price Change Pct: $5.00 - $40.00Is Index Component: GSPC, NDXOne Week Predict Return: 0.0% - 100.0%Monthly Average Dollar Volume: >= 3,000,000

Ticker

Name

Market Cap$

LYB

LyondellBasell Industries NV

23.95B

DOW

Dow Inc

26.96B

OXY

Occidental Petroleum Corp

57.61B

MGM

MGM Resorts International

9.29B

CTVA

Corteva Inc

53.63B

PYPL

PayPal Holdings Inc

40.84B

what about for short term profit

Intellectia · 11 candidates

Price: $5.00 - $100.00List Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20Month Price Change Pct: >= $8.00Is Index Component: GSPC, NDXMonthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

DOW

Dow Inc

26.96B

LYB

LyondellBasell Industries NV

23.95B

OXY

Occidental Petroleum Corp

57.61B

CZR

Caesars Entertainment Inc

5.78B

EQT

EQT Corp

40.39B

Edwards Lifesciences Corp

49.14B

stocks on a uptrend

Intellectia · 15 candidates

Market Cap: >= 5.00BList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Quarter Price Change Pct: >= $60.00Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

IBRX

Immunitybio Inc

9.25B

AAOI

Applied Optoelectronics Inc

7.50B

AZN

AstraZeneca PLC

312.56B

MRNA

Moderna Inc

22.83B

VICR

Vicor Corp

9.22B

ENLT

Enlight Renewable Energy Ltd

10.27B

What is the number one earner today?

Intellectia · 24 candidates

Market Cap: >= 10.00BPrice: >= $5.00Volume: >= 2,000,000Price Change Pct: >= $5.00List Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

COIN

Coinbase Global Inc

48.16B

MSTR

Strategy Inc

44.28B

IREN

IREN Ltd

12.89B

ASTS

AST SpaceMobile Inc

35.41B

NBIS

Nebius Group NV

21.96B

MRNA

Moderna Inc

19.68B

stock fot today buy and sell

Intellectia · 1185 candidates

Market Cap: >= 5.00BRegion: USRelative Vol: >= 2List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20, PriceBelowMA20Week Price Change Pct: $-12.00 - $12.00Monthly Average Dollar Volume: >= 1,500,000

Ticker

Name

Market Cap$

PAAS

Pan American Silver Corp

27.50B

VIAV

Viavi Solutions Inc

6.33B

XP Inc

11.25B

HSIC

Henry Schein Inc

9.49B

WULF

Terawulf Inc

6.56B

SSL

Sasol Ltd

5.59B

bullish stocks this week

Intellectia · 56 candidates

Market Cap: >= 4.00BRegion: USList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: >= $10.00Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

MASI

Masimo Corp

9.43B

IBRX

Immunitybio Inc

8.41B

ONDS

Ondas Inc

4.98B

MRNA

Moderna Inc

18.21B

ELF

elf Beauty Inc

5.20B

KTOS

Kratos Defense and Security Solutions Inc

17.84B

whats the next stock to watch for swing

Intellectia · 19 candidates

Rsi Category: moderateBeta: HighRiskList Exchange: XNASMoving Average Relationship: PriceAboveMA200Is Index Component: NDXMonthly Average Dollar Volume: >= 2,000,000

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

4.21T

TSLA

Tesla Inc

1.52T

Micron Technology Inc

413.22B

AMZN

Amazon.com Inc

2.50T

AMD

Advanced Micro Devices Inc

327.97B

AVGO

Broadcom Inc

1.42T

which stocks have unusual options activity

Intellectia · 9 candidates

Market Cap: >= 500.00MPrice: $5.00 - $500.00List Exchange: XNYS, XNAS, XASEIs Optionable: TrueOption Unusual Activity: TrueMonthly Average Dollar Volume: >= 500,000

Ticker

Name

Market Cap$

ASTS

AST SpaceMobile Inc

38.93B

MRNA

Moderna Inc

18.33B

UNH

UnitedHealth Group Inc

316.50B

COIN

Coinbase Global Inc

57.92B

BEN

Franklin Resources Inc

13.32B

FUN

Six Flags Entertainment Corp

1.76B

Whales Holding MRNA

Two Sigma Investments, LP

Tang Capital Management, LLC

Y-Intercept (Hong Kong) Limited

Himension Capital (Singapore) Pte Ltd

Aquatic Capital Management LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Moderna Inc (MRNA) stock price today?

The current price of MRNA is 50.03 USD — it has decreased -1.52

What is Moderna Inc (MRNA)'s business?

What is the price predicton of MRNA Stock?

Wall Street analysts forecast MRNA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MRNA is32.47 USD with a low forecast of 17.00 USD and a high forecast of 63.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Moderna Inc (MRNA)'s revenue for the last quarter?

Moderna Inc revenue for the last quarter amounts to 678.00M USD, decreased -29.81

What is Moderna Inc (MRNA)'s earnings per share (EPS) for the last quarter?

Moderna Inc. EPS for the last quarter amounts to -2.11 USD, decreased -26.99

How many employees does Moderna Inc (MRNA). have?

Moderna Inc (MRNA) has 4700 emplpoyees as of April 02 2026.

What is Moderna Inc (MRNA) market cap?

Today MRNA has the market capitalization of 19.84B USD.

MRNA Overview

MRNA Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding MRNA

Trading Trends

People Also Watch

Frequently Asked Questions

What is Moderna Inc (MRNA) stock price today?

What is Moderna Inc (MRNA)'s business?

What is the price predicton of MRNA Stock?

What is Moderna Inc (MRNA)'s revenue for the last quarter?

What is Moderna Inc (MRNA)'s earnings per share (EPS) for the last quarter?

How many employees does Moderna Inc (MRNA). have?

What is Moderna Inc (MRNA) market cap?